NHS National Framework for Ferric Carboxymaltose injection

NHS National Framework for Ferric Carboxymaltose

Offer reference number: CM/TNS/26/5743

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

CM/TNS/26/5743 Ferric Carboxymaltose

Lot 1 CESW 01/03/2027 to 31/01/2029 (23 months)

Lot 2 NWLN 01/03/2027 to 31/05/2028 (15 months)

Lot 3 LSNE 01/03/2027 to 31/05/2028 (15 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England